133 related articles for article (PubMed ID: 36042171)
1. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model.
Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
[TBL] [Abstract][Full Text] [Related]
4. Synergic effect of PD-1 blockade and endostar on the PI3K/AKT/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model.
Wu J; Zhao X; Sun Q; Jiang Y; Zhang W; Luo J; Li Y
Biomed Pharmacother; 2020 May; 125():109746. PubMed ID: 32106386
[TBL] [Abstract][Full Text] [Related]
5. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
[TBL] [Abstract][Full Text] [Related]
6. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.
Wu H; Deng J; Yu S; Wang X; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):108-12. PubMed ID: 20155466
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
[TBL] [Abstract][Full Text] [Related]
11. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antiangiogenic activity of tetrandrine combined with Endostar on the human umbilical vein endothelial cell model.
Qian X; Yan B; Zhou X; Xie L; Wei J; Li R; Yu L; Liu B
Cancer Biother Radiopharm; 2013 Jun; 28(5):385-90. PubMed ID: 23682584
[TBL] [Abstract][Full Text] [Related]
13. Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway.
Xu X; Mao W; Chen Q; Zhuang Q; Wang L; Dai J; Wang H; Huang Z
PLoS One; 2014; 9(9):e107463. PubMed ID: 25232946
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
[TBL] [Abstract][Full Text] [Related]
15. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
17. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of endostar in combination with radiotherapy in a mouse model of human CNE2 nasopharyngeal carcinoma.
Zhou N; Hu G; Mei Q; Qiu H; Long G; Chen C; Guoqing H
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):62-66. PubMed ID: 21336725
[TBL] [Abstract][Full Text] [Related]
19. Endostar inhibits hypoxia-induced cell proliferation and migration via the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in vitro.
Lin K; Ye P; Liu J; He F; Xu W
Mol Med Rep; 2015 May; 11(5):3780-5. PubMed ID: 25543905
[TBL] [Abstract][Full Text] [Related]
20. The crosstalk between lung cancer cells and platelets promotes tumor angiogenesis in vivo and in vitro.
Li B; Zhu T; Wu X; Chen S; Lu C; Zhu J; Li Q
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3495-3511. PubMed ID: 35951091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
